By purchasing any products from Pure7 through this website, you acknowledge that all items are intended for research purposes only. Additionally, you agree to the terms and conditions outlined below.
Products containing 7-hydroxymitragynine are highly concentrated. Therefore, you must not use these products without first consulting a licensed medical professional. Ask specifically about CYP enzyme inhibition, potential interactions, and safe handling requirements.
Do not combine 7OH or related alkaloids with any other substances, medications, or alcohol. If you suspect dependency or adverse effects, immediately seek medical or addiction support.
DO NOT USE THIS PRODUCT IF YOU ARE PREGNANT OR NURSING.
These products have not been evaluated by the FDA and may pose health risks. They are not intended to diagnose, treat, cure, or prevent any disease. Keep out of reach of children.
PROP 65 Warning: Products may contain chemicals known to the state of California to cause reproductive harm. Visit P65Warnings.ca.gov for more information.
Products contain concentrated alkaloids derived from Mitragyna speciosa. These concentrations are significantly stronger than raw leaf or traditional extracts. Kratom-containing products may cause risks including liver injury, drug interactions, addiction, abuse, withdrawal symptoms, and—in severe cases—death.
The DEA has stated that consumption of Mitragyna Speciosa may lead to addiction. Visit FDA.gov for official advisories.
By purchasing these products, you assume full responsibility for any adverse effects or health outcomes resulting from improper use, misuse, or consumption.
We do not ship to any U.S. state, county, or municipality where kratom, mitragynine, or 7OH is restricted or banned. Buyers must be 18+ or 21+ as required by local laws.
Pure7, including its officers, directors, employees, affiliates, and parent companies, shall not be liable for any damages arising from the purchase, possession, or use of products obtained through this website. This includes indirect, consequential, or special damages.
You agree to indemnify and hold harmless Pure7 and its affiliates from any claims, expenses, liabilities, or damages arising from your breach of these Terms or misuse of the products.
These Terms are governed by the laws of the State of Delaware. All disputes must be resolved exclusively in Delaware State or Federal Courts. You waive any right to challenge venue or request transfer.
All disputes related to the purchase or use of Pure7 products must be resolved through binding arbitration administered by the American Arbitration Association (AAA). Three arbitrators will oversee the process: one appointed by Pure7, one by the purchaser, and one jointly selected. If no agreement is reached, AAA rules will determine the third arbitrator.
The arbitration will take place in Delaware unless both parties agree otherwise. The arbitration decision is final and enforceable.
You waive the right to participate in class-action lawsuits or collective legal claims of any kind.
Pure7 may assign or transfer its rights under these Terms at any time. Buyers may not assign their rights without prior written consent.
Pure7 may revise these Terms at any time. By continuing to use the website or making purchases, you agree to review these Terms periodically for changes.
If any section of these Terms is determined to be invalid, the remaining sections shall continue in full force.
By completing a purchase on this website, you affirm the following:
These Terms constitute the complete agreement between you and Pure7 regarding your product purchase. Any verbal or implied agreements are void unless documented in writing.
Stay informed with exclusive product releases, discounts, lab report updates, and early access to new 7OH innovations.
Sign up to receive:
Exclusive discount codes
Early product announcements
Research insights
Wholesale opportunities
Special member-only offers
PURÉ7 is an official brand specializing in premium 7-Hydroxymitragynine (7OH) research products, crafted with transparency, integrity, and strict quality standards. We provide trusted, lab-verified 7OH tablets for authorized research purposes across the United States.
CONTACT US! support@getpure7.com | 1 402-527-8737
WARNING: 7-Hydroxymitragynine (7OH) products are intended for research use only.
Not for human consumption.
Keep out of reach of children.
Pure 7-OH Products are not available for shipment to the following States: Alabama, Arkansas, Florida, Indiana, Georgia, Oklahoma, Rhode Island, Wisconsin; or the following counties: Sarasota County (Florida), San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Rapides (Louisiana)
Select Products are Compliant for Georgia and parts of Florida
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease
PURÉ7 is a trusted leader in 7-Hydroxymitragynine (7OH), offering high-purity, lab-tested tablets designed for reliable research applications. We provide fast U.S. shipping, transparent COAs, and consistent potency across every batch. Whether you’re searching for 7OH tablets, 7OH wholesale options, or research-grade 7-Hydroxymitragynine, PURÉ7 delivers unmatched quality and integrity.
Pure 7 Hydroxymitragynine
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to